Dr. Carlos Arias-Cabrales, Spain
Impact of delayed graft function without dialysis needed

Dr. Shaifali Sandal, Canada
Perioperative hemoglobin and delayed graft function in kidney transplant recipients

Prof. Jialin Zhang, P.R. China
Clinical analysis of impact of intraoperative hepatic blood inflow on acute kidney injury following allogeneic liver transplantation

Dr. Verushka Reddy, South Africa
Analysis of uric acid and other factors affecting renal function in the monitoring of renal transplant recipients

Dr. Rafael A Maldonado, Argentina
Use of electron microscopy (EM) to detect transplant glomerulopathy (TG) in patients with late-indication allograft biopsy

Dr. Asuncion Sancho Calabuig, Spain
Is the donor age a real limitation to the use of very extended criteria donors in kidney transplantation?

Dr. Joanna Pazik, Poland
Risk factors of graft loss in renal transplant recipients including histopathological changes present in implanted kidney

Mrs. Ester Casillas Sagrado, Spain
Kidney allograft survival in oldest donors

Mrs. Agne Laucyte-Cibulskiene, Lithuania
ABO incompatibility does not have an influence on kidney graft survival in living related donor transplantation

Prof. Ji Il Kim, Korea
Long-term outcomes of ABO-incompatible living donor kidney transplantation compared with ABO-compatible grafts: A single-center experience in Korea

Ms. Jee Yeon Kim, Korea
Analysis of 400 ABO incompatible kidney transplantations: A single center experience

Dr. Sonia Mehrotra, India
Immunological barriers in ABO-incompatible kidney transplantation: How to overcome

Dr. Amit Sharma, India
ABO incompatible renal transplantation without anti-CD20 treatment or splenectomy: Comparison with blood group compatible renal transplantation.

Ron Shapiro, United States
A2 to B renal transplantation: One center's experience and the implications for decreasing wait times and reducing racial disparities in organ allocation

Miss Noémi Janszky, Germany
Examination of serum miRNAs as possible biomarkers for the diagnosis of acute rejection after kidney transplantation

Dr. Petra Hruba, Czech Republic
Early borderline changes represent a risk for T-cell mediated rejection and graft failure in kidney transplantation

Dr. Marco Antonio Carmona, Mexico
C4d 100% positive in renal biopsy of patient with acute graft dysfunction successfully managed with bortezomib, clinical case

Dr. Evgenia Preka, United Kingdom
Improved diagnosis and management of paediatric renal transplant recipients using the Banff 2013 histopathological classification

Dr. Juan Irure-Ventura, Spain
Soluble BAFF levels are associated with antibody mediated rejection in kidney transplant recipients

Dr. Jeffrey P Mora, Philippines
Patient and graft outcome among high immunologic risk renal transplant recipients

Dr. Tomokazu Shimizu II, Japan
Clinical and pathological analyses of cases of acute vascular rejection after kidney transplantation

Dr. Tomoko Namba-Hamano, Japan
Kidney allograft histology in recipients with transplantation vintage longer than 10 years

Dr. Nora Imperiali, Argentina
Risk factors for transplant vasculopathy in kidney transplant

Dr. A.Osama Gaber, United States
Clinical and pathologic outcomes of incidental IgA glomerular deposits (IgAGD) in donated kidneys in an ethnically diverse region of the USA

Prof. Soo Jin Na Choi, Korea
Kidney transplantation from deceased donor with fibromuscular dysplasia

Seong Sik Kang, Korea
Characteristics of patients with functioning allograft over 10 years in deceased donor kidney transplantation

Dr. Tinus Du Toit, South Africa
Kidney transplantation utilising donors after circulatory death – the first report from the African continent

Dr. Roberto C Manfro, Brazil
Outcomes of kidney transplantation from expanded-criteria deceased donors in a single center

Dr. Javier Juega, Spain
Similar outcomes of kidney transplant program from controlled cardiac death donors compared with kidney transplant from brain dead donors after 2 years of follow up

Prof. Feza Yarbug Karakayali, Turkey
Comparison of kidney extraction incisions in laparoscopic living donor nephrectomy: A single-center experience

Dr. Kiyokazu Akioka, Japan
Living kidney transplantation from marginal donors with diabetes. Report of prognosis and outcomes of 5 pairs of recipients and donors

Dr. Takayoshi Yokoyama, Japan
Clinical outcomes in recipients of living-donor kidney transplantation by donor age group

Ms. Abeera Ali, Canada
South Asian and Muslim Canadian patients are less likely to receive living donor kidney transplant offers compared to Caucasian, non-Muslim patients

Dr. Martin Mai, United States
Collaboration converts cardiac catastrophe during living donor kidney recipient surgery to long term success

Ms. Kyungok Min, Korea
Barriers to living kidney donation: A single-center experience

Dr. Rehan Mohsin, Pakistan
Outcomes of laparoscopic donor nephrectomy in presence of double renal arteries – an early experience in a developing country

Dr. Naotake Akutsu, Japan
Summary of retroperitoneoscopic nephrectomy for living donor kidney transplantation in a single institution

Dr. Takeshi Ishimura, Japan
Adequate timing to visit transplant center for patient intending pre-emptive living–donor kidney transplantation

Mrs. Sandra Dzwonkowska, Poland
Transplant renal artery stenosis (TRAS) in the early post-transplantation period

Dr. Lina Hua, Australia
Correlation between CT volumetry and nuclear medicine split renal function in live kidney donation - a single centre experience

Dr. Engida Abebe Gelan, Ethiopia
Establishing a living donor kidney transplant program in Sub-Saharan African country: Living kidney donor characteristics and outcomes in Ethiopia

Dr. German A Mir Sr., Argentina
Causes of exclusion of a living kidney donor in a public hospital in a developing country

Dr. Funda Ulu Öztürk, Turkey
Importance of regular ultrasound imaging in renal allografts for early diagnosis of de novo renal cell carcinoma: A report of two rare cases

Dr. Jordi Rovira, Spain
Different expression patterns of exosomal miRNAs under cyclosporin A and rapamycin treatment in distinct aggressiveness colorectal carcinomas

Mr. Jacek Zawierucha, Poland
Malignancy prevalence in waitlisted potential kidney transplant recipients is very low relative to patients after kidney transplantation

Dr. Ji Yoon Choi, Korea
Prevention of hepatitis B virus reactivation in HBsAg-positive renal transplant recipients with Rituximab treatment

Dr. Feride Kural Rahatli, Turkey
Shear wave elastography findings of achilles tendons in patients on chronic hemodialysis and patients with renal transplantation

Prof. Zeynep Kayhan, Turkey
Orthotopic renal transplantation with spleno-renal shunt

Prof. Kenan Caliskan, Turkey
Corner-saving renal artery anastomosis for renal transplantation

Prof. Kazunari Yoshida, Japan
Positive effects of early intervention of renal rehabilitation on kidney transplant patients

Prof. Bulang He, Australia
Outcomes of kidney transplantation by laparoscopic surgery versus open surgery

Dr. Min Jung Kim, Korea
Impact of induction immunosuppression on the recurrence of primary IgA nephropathy

Dr. Tania Janaudis-Ferreira, Canada
Identifying what aspects of the post-kidney transplant experience affect quality of life: Setting the stage for a patient-centered intervention to optimize recovery post-transplant

Dr. Yusuke Yamada, Japan
Planned genetic diagnosis of atypical hemolytic Uremic syndrome and successful preemptive treatment with eculizumab for recurrence after cadaveric kidney transplantation: Case report

Miss Jiye Ha, Korea
Factors associated with waiting time to deceased donor kidney transplantation in transplant recipients

Mr. Dmitri Belenko, Canada
Validation of the PROMIS-57 and PROMIS-29 profile questionnaires in kidney transplant recipients

Dr. Cristian M. Alvarez, Colombia
A retrospective study of the immunological and non-immunological factors associated with kidney allograft rejection in two transplant centres in Medellin, Columbia

Ms. Brittany A Shelton, United States
Increasing obesity and diabetes prevalence in the United States end-stage renal disease population

Dr. Antonio S. Moreno Salazar, Spain
Returning to dialysis after kidney transplant failure does the dialysis treatment modality influence the survival prognosis?

Miss Joo Hee Jung, Korea
Clinical outcome after simultaneous heart and kidney transplantation

Mr. Atul Bagul, United Kingdom
Comparison of sleep quality in hemodialysis vs kidney transplant recipients using Pittsburgh Sleep Quality Index (PSQI).

Mr. John T Black, United Kingdom
Allograft trauma in transplant recipients. A case series

Adam D Barlow, United Kingdom
Parvovirus causing severe anaemia in kidney transplant recipient. A case report

Dr. Nuria Serra, Spain
Monoclonal gammopathy of renal significance in kidney transplantation: De novo C3 glomerulonephritis

Dr. Mercedes M Ruiz Hernández, Spain
Kidney autotransplantation: Long-term outcomes and complications. 26-years experience in a tertiary hospital

Dr. Mahir Kirnap, Turkey
Effect of rat urine on ileum muscle layer of bladder reconstruction: An experimental study

Sara Jiménez, Spain
Renal transplant from living donor in a patient of very high surgical risks due to Takayasu disease and several course of vascular thrombosis

Prof. Sedat Yildirim, Turkey
Renal transplantation for Vacterl syndrome

Dr. Sigal Aizner, Israel
Successful kidney re-transplantation of a transplanted kidney 9 years after the first transplant

Dr. Mohamed O A E M Ahmed, United Kingdom
Polypharmacy in renal transplant recipients

Dr. Susana M. Norton, Portugal
Renal transplantation in patients with hereditary fibrinogen amyloidosis

Ms. Katriona JM O'Donoghue, United Kingdom
Do the online materials provided by United Kingdom renal transplant centres adequately answer questions asked by transplant recipients, patients on the transplant waiting list, carers and live kidney donors?

Ms. Elsaline Rijkse, Netherlands
The impact of aorto-iliac calcifications on patient and graft survival in renal transplant recipients using the TASCII classification

Mr. Javier De Teresa Alguacil, Spain
Patient´s death with a functioning graft is still the most common cause of kidney transplant loss

Prof. Mauricio Sainz Barriga, Belgium
Intraoperative renal perfusion in kidney transplantation: A retrospective study

Mekdim Tadesse Siyoum, Ethiopia
Live donor kidney transplant outcomes till February 2018 in the first kidney transplant center in Ethiopia

Ms. Fiona Chun Chi Foo, Singapore
Quality of ambulatory transplant care in a tertiary transplant center

Ms. Maryn Reyneke, South Africa
A systems thinking approach: Barriers to implementation of an HIV-to-HIV positive transplant program in the state sector of South Africa

Prof. Jae Yoon Park, Korea
Comorbidities can predict the mortality of kidney transplant recipients: Comparison with the Charlson comorbidity index

Allison Tong, Australia
Outcome measures for life participation in patients with kidney transplantation

Prof. Sam Minh Thai, Viet Nam
Evaluating the Results of Preemptive Kidney Transplantation at Cho Ray Hospital

Dr. Elif Kupeli, Turkey
The relationship between CMV seropositivity and fungal pneumonia in renal transplant patients

Prof. Karl L Womer, United States
A pilot study of immunosuppression resumption following BK viremia resolution

Dr. Veronica Lopez, Spain
Role of the early association of a mTOR inhibitor and tacrolimus in BK polyomavirus infection in kidney transplant recipients

Dr. Luis R Leon, Argentina
Polyomavirus BK-associated nephropathy after kidney transplantation: A single-center retrospective analysis

Dr. Taehee Kim, Korea
Patients undergoing peritoneal dialysis at the time of kidney transplantation are more likely to have higher LDH-cholesterol than non-dialysis dependent chronic kidney disease patients: Korean organ transplantation registry cohort study

Dr. Giuseppe Ietto, Italy
Pretransplant nephrectomy for large polycystic kidneys in ADPKD (autosomal dominant polycystic kidney disease) patients: Is possible peritoneal dialysis recovery after surgery?

Dr. Christos Nikolaidis, Greece
Indications and Timing of Native Nephrectomy for Renal Transplant Recipients with End-Stage Polycystic Kidney Disease. A Literature Review

Dr. Maximilien Roumain, Belgium
Shipped versus locally transplanted kidneys: No impact on early and late renal function

Dr. Juraj Miklušica, Slovakia (Slovak Republic)
FlowPRA screening of antiHLA antibodies in the waiting list significantly reduces the occurrence of acute rejection after kidney transplantation

Dr. Diederik H.J.A.N. Kimenai, Netherlands
Safety and efficacy of third kidney transplantation in ipsilateral iliac fossa

Cinthia B. Drachenberg, United States
Pattern of glomerular staining for C4d immunohistochemistry is useful for the diagnosis of immune complex mediated glomerulonephritis in renal allograft biopsies

Dr. Akira Tadokoro, Japan
Long-term outcome of kidney transplantation for IgA nephropathy: A single-center experiences.

Dr. Samuel Lee, Korea
Identification of urinary biomarkers for recurrence of IgA nephropathy after kidney transplantation using proteomic methods

Dr. Burak Sayin, Turkey
Early conversion to mTOR inhibitors prevents kidney function better than late conversion

Dr. Jose Luis Santiago, Spain
Effect of interferon-gamma gene polymorphism +874 A/T on cytomegalovirus infection in kidney transplant recipients with and without prophylactic treatment with valganciclovir

Dr. Ernesto J Fernández, Spain
Renal transplantation in patients with induction based in m-TOR inhibitors: early renal function and associated factors

Dr. Seow Yeing Yee, Malaysia
Everolimus conversion in kidney transplant recipients: Is it safe?

Prof. Alain G Assounga, South Africa
Long term follow up after conversion from calcineurin inhibitors to sirolimus in a South African renal transplant population

Dr. Nobuhiro Fujiyama, Japan
Immunosuppression related to de novo donor-specific HLA antibody production after renal transplantation

Mr. Binay Gurung, United Kingdom
Effect of ethnicity on tacrolimus (adoport) trough concentrations in renal transplant recipients. A single centre retrospective study

Randall Lou-Meda, Guatemala
Transplant cost reduction in a developing country: “The case of Guatemala”

Dr. Vladimir Tennak, Israel
A single dose thymoglobulin in non-sensitized deceased donor kidney recipients >60 years

Dr. Akhil Sharma, United States
High calcineurin inhibitor intra patient variability is associated with early renal allograft inflammation, chronicity and loss

Dr. Kim Bul, United Kingdom
Correlation between mycophenolate dosage and occurrence of adverse effects in renal transplant patients

Dr. Kim Bul, United Kingdom
Using the Japanese KJ Ho method as a qualitative creative problem solving technique to address clinicians’ and young kidney transplant patients’ needs concerning treatment

Dr. Jose Cruz Santiago, Mexico
Clinical experience of 6 years with rabbit anti-thymocyte globulin as induction therapy in renal transplant receptors